EGFR and neoplasm: This is particularly the case with kirsten rat sarcoma viral oncogene (KRAS), an intracellular effector molecule that routs ligand-bound EGFR to the nucleus, where it leads to constitutive phosphorylation of the receptor and hence tumor proliferation.